Identification | Back Directory | [Name]
Farletuzumab | [CAS]
896723-44-7 | [Synonyms]
Farletuzuma Farletuzumab Farletuzumab (anti-FOLR1) Research Grade Farletuzumab(DHD10401) |
Hazard Information | Back Directory | [Uses]
Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer[1]. | [References]
[1] Ebel W, et, al. Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha. Cancer Immun. 2007 Mar 9;7:6. PMID:17346028 |
|
Company Name: |
Biolab Reagents
|
Tel: |
18108604356 18108604356 |
Website: |
www.biolabreagent.com/ |
|